 |
Columbia University College of Physicians and Surgeons | |
| City: New York | State: NY | |
|
Links:
Commentary:Columbia University College of Physicians and Surgeons submitted a strong policy, in need of minor improvements. Model domains include speaking and purchasing, with a policy clearly prohibiting participation in "speaker's bureaus" and requiring disclosure and recusal for purchasing committee members engaged in a financial conflict of interest with a company of interest. Improvements are needed in the area related to samples, as the policy is limited on the restriction of samples as a marketing tool. The policy's gift domain could be stronger, by prohibiting both gifts and on-site meals, which are fully capable of presenting conflicts of interest with industry. The policy currently prohibits only gifts. Overall this policy is advancing in the right direction, with a model curriculum, oversight and sanctions for noncompliance.
Updates: This institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard. This institution has not consented to the posting of their policies on this website for illustrative purposes. This institution's evaluation was last updated: 02/29/2012 |
||
| Gifts & Meals |  |
The policy prohibits gifts of any value, and on-site meals are restricted to CME programming. |
| Consulting relationships |  |
The policy requires that all consulting agreements must be first approved but does not require that payment be commensurate with the task or that the arrangement be described in a formal contract. |
| Industry-funded speaking relationships | |
The policy clearly defines speakers bureaus and then prohibits participation in speaking arrangements which meet the speakers bureau definition. Also, speakers must be in full control of their material. |
| Disclosure | |
The policy mandates annual disclosure of all financial relationships for staff and anticipates the launch of a public disclosure website in 2012, which will include some, not all, of the financial ties of staff. |
| Pharmaceutical samples |  |
The policy presents regulations for sample storage, access and distribution and retricts samples for patient use. However, clinicians are permitted to receive samples and there are no marketing restrictions on samples. |
| Purchasing & Formularies | |
All Purchasing & Formulary committee members must disclose financial interests at least annually. |
| Industry Sales Representatives | |
The policy states that industry sales representatives may only meet with faculty by appointment. |
| On-campus Education | |
Industry supported, on-site educational activities funds require institutional review. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | |
Industry support of travel is limited to payment for legitimate professional speaking and consulting engagements. However, the policy makes no reference to the receipt of payment for attendance at off-site events |
| Industry Support for Scholarships & Funds for Trainees | |
Oversight of travel funds is established through the AMC's respective departments. |
| Medical school curriculum | |
The supplied curriculum lists a wide range of ethical and professional issues surrounding industry funded research, the effects of industry gifts in the clinical setting along with an excellent list of suggested scientific readings. |
| Do the policies specify an oversight mechanism? |  |
Oversight is established |
| Are there explicit sanctions for noncompliance? | |
Sanctions are referenced. |
 | |
 | Model policy |
 | Good progress toward model policy |
 | No policy, or policy unlikely to have a substantial effect on behavior |
 | Did not report |
 | Policy not relevant to this institution (e.g., does not make purchasing decisions) |
